Literature DB >> 18613221

Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.

Yuhao Li1, Yanfei Qi, Moon Sun Kim, Kevin Zhe-Yang Xu, Tom Hsun-Wei Huang, Xianglu Rong, Michael Murray, Johji Yamahara.   

Abstract

BACKGROUND: Zucker diabetic fatty (ZDF) rat is a genetic model of type 2 diabetes and obesity. The mechanism underlying nephropathy in ZDF rats, however, remains unclear.
METHODS: ZDF rats were compared to age-matched Zucker lean (ZL) rats. Physiological and blood biochemical parameters, renal glomerular cross-sectional area (hematoxylin-eosin staining), fibrosis (van Giesen staining), collagen composition (Sircol Collagen Assay), lipids (enzymatic method) and mRNA expression (RT-PCR) were determined.
RESULTS: ZDF rats showed an increase in renal-insoluble collagen content and the ratio of renal-insoluble to salt-soluble collagen (2- and 1.5-fold of the control animals). There were increases in renal glomerulosclerosis and interstitial fibrosis in ZDF rats (increased to 2-fold) in the glomerular mesangium and tubulointerstitium, and increased glomerular area. Renal triglyceride accumulated to greater than 2-fold of those levels in ZL rats. These changes were accompanied by hypoalbuminemia, and elevated plasma blood urea nitrogen and uric acid levels. Gene profiling showed increased expression of transcripts encoding the glomerulosclerotic mediator collagens I and IV, plasminogen activator inhibitor-1, transforming growth factor-beta1, and angiotensin II type 1 receptor in ZDF rat kidney. Moreover, renal expression of mRNAs encoding sterol regulatory element-binding protein-1, a nuclear transcription factor that activates genes involved in fatty acid synthesis, and acetyl-CoA carboxylase, a key enzyme that mediates fatty acid synthesis, was increased in ZDF rats.
CONCLUSIONS: Our findings suggest that dysregulated gene expression may result in increased renal collagen cross-linking and lipid accumulation, that may be associated with development of nephropathy in the animal model of type 2 diabetes and obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18613221     DOI: 10.1002/dmrr.874

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  11 in total

1.  Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.

Authors:  Jorge E Toblli; Gabriel Cao; Jorge F Giani; Margarita Angerosa; Fernando P Dominici; Nestor F Gonzalez-Cadavid
Journal:  Kidney Blood Press Res       Date:  2010-11-11       Impact factor: 2.687

2.  Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats.

Authors:  Rupinder Kaur; Rupinder Kaur Sodhi; Neha Aggarwal; Jaspreet Kaur; Upendra K Jain
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-10-16       Impact factor: 3.000

3.  Aerobic exercise training combined or not with okra consumption as a strategy to prevent kidney changes caused by metabolic syndrome in Zucker rats.

Authors:  Monique Marques da Silva; Moisés Felipe Pereira Gomes; Elizabeth de Orleans Carvalho de Moura; Mariana Matera Veras; Melina Chiemi Kubota; Ana Paula Takano; Ana Carolina Cardoso Dos Santos; Carolina Gonçalves Dos Reis José; Graziele Aparecida da Silva Souza; Naiara Magalhães Cardoso; Debora Estadella; Rafael Herling Lambertucci; Alessandra Medeiros
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

4.  Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.

Authors:  Lei Dong; Yue-Qiang Li; Shui-Ming Guo; Gang Xu; Wang Wei; Min Han
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.

Authors:  Jorge E Toblli; Monica G Ferrini; Gabriel Cao; Dolores Vernet; Margarita Angerosa; Nestor F Gonzalez-Cadavid
Journal:  Nephrol Dial Transplant       Date:  2009-03-17       Impact factor: 5.992

Review 6.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

7.  Protective effect of Garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet.

Authors:  Kamal A Amin; Hamdy H Kamel; Mohamed A Abd Eltawab
Journal:  Lipids Health Dis       Date:  2011-01-14       Impact factor: 3.876

Review 8.  Advances in murine models of diabetic nephropathy.

Authors:  Li-Li Kong; Hao Wu; Wen-Peng Cui; Wen-Hua Zhou; Ping Luo; Jing Sun; Hang Yuan; Li-Ning Miao
Journal:  J Diabetes Res       Date:  2013-06-13       Impact factor: 4.011

9.  The Ayurvedic Medicine Salacia oblonga Attenuates Diabetic Renal Fibrosis in Rats: Suppression of Angiotensin II/AT1 Signaling.

Authors:  Lan He; Yanfei Qi; Xianglu Rong; Jianmin Jiang; Qinglin Yang; Johji Yamahara; Michael Murray; Yuhao Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

10.  Ginger extract diminishes chronic fructose consumption-induced kidney injury through suppression of renal overexpression of proinflammatory cytokines in rats.

Authors:  Ming Yang; Changjin Liu; Jian Jiang; Guowei Zuo; Xuemei Lin; Johji Yamahara; Jianwei Wang; Yuhao Li
Journal:  BMC Complement Altern Med       Date:  2014-05-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.